Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes.
Gilberto VelhoStéphanie RagotRay El BoustanyPierre-Jean SaulnierMathilde FratyKamel MohammediFrédéric FumeronLouis PotierMichel MarreSamy HadjadjRonan RousselPublished in: Cardiovascular diabetology (2018)
Plasma copeptin was positively associated with major cardiovascular events in people with type 2 diabetes. This association cannot be solely accounted for by the association of copeptin with kidney-related traits.